Physician profile
Brian Matthew Fiddler
NPI 1235293150
$5,632.91
in general payments reported to CMS, 2019-2025
16 companies · $1,193 in 2025
The $1,193 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,095 · 2020: $279 · 2021: $396 · 2022: $677 · 2023: $979 · 2024: $1,014 · 2025: $1,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,186.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,110.08 | 2022-2025 | Miebo, Infuse, Xiidra |
| Johnson & Johnson Vision Care, INC. | $784.64 | 2019-2025 | Acuvue |
| Coopervision INC. | $709.27 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $671.72 | 2019-2025 | Dailies Total1, Total30, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $385.77 | 2019-2021 | |
| Dompe US, INC. | $344.37 | 2023-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $295.09 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $275.26 | 2019-2022 | |
| Shire North American Group INC | $266.22 | 2019 | |
| Glaukos Corporation | $240.68 | 2019-2025 | Idosetr |
| Abbvie INC. | $141.03 | 2022-2023 | |
| Allergan, INC. | $136.85 | 2019 | |
| Aerie Pharmaceuticals, INC. | $122.12 | 2019 | |
| Oyster Point Pharma, INC. | $92.10 | 2022-2023 | Tyrvaya |
| Rxsight INC | $38.46 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Handpiece |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $19.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Fiddler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.